These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 24055406
1. Driver mutations among never smoking female lung cancer tissues in China identify unique EGFR and KRAS mutation pattern associated with household coal burning. Hosgood HD, Pao W, Rothman N, Hu W, Pan YH, Kuchinsky K, Jones KD, Xu J, Vermeulen R, Simko J, Lan Q. Respir Med; 2013 Nov; 107(11):1755-62. PubMed ID: 24055406 [Abstract] [Full Text] [Related]
2. Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers. Dogan S, Shen R, Ang DC, Johnson ML, D'Angelo SP, Paik PK, Brzostowski EB, Riely GJ, Kris MG, Zakowski MF, Ladanyi M. Clin Cancer Res; 2012 Nov 15; 18(22):6169-77. PubMed ID: 23014527 [Abstract] [Full Text] [Related]
7. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing. Liu Y, Wu BQ, Zhong HH, Hui P, Fang WG. Int J Clin Exp Pathol; 2013 Nov 15; 6(9):1880-9. PubMed ID: 24040454 [Abstract] [Full Text] [Related]
8. EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study. Bircan S, Baloglu H, Kucukodaci Z, Bircan A. Med Oncol; 2014 Aug 15; 31(8):87. PubMed ID: 24973952 [Abstract] [Full Text] [Related]
10. Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases. Sun Y, Ren Y, Fang Z, Li C, Fang R, Gao B, Han X, Tian W, Pao W, Chen H, Ji H. J Clin Oncol; 2010 Oct 20; 28(30):4616-20. PubMed ID: 20855837 [Abstract] [Full Text] [Related]
11. [Relationship between EGFR and K-ras mutations and clinicopathological characteristics and response to erlotinib treatment in 301 Chinese patients with non-small cell lung cancer]. Sun LN, Luan HL, Zang FL, Wang M, Dong N, Guo Y, Sun BC, Zhan ZL. Zhonghua Zhong Liu Za Zhi; 2010 Sep 20; 32(9):667-70. PubMed ID: 21122380 [Abstract] [Full Text] [Related]
16. Lungs don't forget: Comparison of the KRAS and EGFR mutation profile and survival of collegiate smokers and never smokers with advanced lung cancers. Varghese AM, Sima CS, Chaft JE, Johnson ML, Riely GJ, Ladanyi M, Kris MG. J Thorac Oncol; 2013 Jan 20; 8(1):123-5. PubMed ID: 23242442 [Abstract] [Full Text] [Related]
18. Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis. Zhang Y, Sun Y, Pan Y, Li C, Shen L, Li Y, Luo X, Ye T, Wang R, Hu H, Li H, Wang L, Pao W, Chen H. Clin Cancer Res; 2012 Apr 01; 18(7):1947-53. PubMed ID: 22317764 [Abstract] [Full Text] [Related]
19. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium. Villaruz LC, Socinski MA, Abberbock S, Berry LD, Johnson BE, Kwiatkowski DJ, Iafrate AJ, Varella-Garcia M, Franklin WA, Camidge DR, Sequist LV, Haura EB, Ladanyi M, Kurland BF, Kugler K, Minna JD, Bunn PA, Kris MG. Cancer; 2015 Feb 01; 121(3):448-56. PubMed ID: 25273224 [Abstract] [Full Text] [Related]